Product NDC: | 0338-0221 |
Proprietary Name: | Plasma-Lyte A |
Non Proprietary Name: | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
Active Ingredient(s): | 30; 37; 368; 526; 502 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL & nbsp; Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-0221 |
Labeler Name: | Baxter Healthcare Coporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017378 |
Marketing Category: | NDA |
Start Marketing Date: | 19790202 |
Package NDC: | 0338-0221-03 |
Package Description: | 500 mL in 1 BAG (0338-0221-03) |
NDC Code | 0338-0221-03 |
Proprietary Name | Plasma-Lyte A |
Package Description | 500 mL in 1 BAG (0338-0221-03) |
Product NDC | 0338-0221 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19790202 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Coporation |
Substance Name | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE |
Strength Number | 30; 37; 368; 526; 502 |
Strength Unit | mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |